Quantcast
Home > Quotes > BLRX

BioLineRx Ltd. American Depositary Shares (BLRX) Quote & Summary Data

BLRX 
$0.371
*  
0.004
1.07%
Get BLRX Alerts
*Delayed - data as of Apr. 22, 2019 13:55 ET  -  Find a broker to begin trading BLRX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BLRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.374 / $ 0.3869
1 Year Target
3
Today's High / Low
$ 0.3898 / $ 0.3631
Share Volume
162,611
50 Day Avg. Daily Volume
1,182,290
Previous Close
$ 0.375
52 Week High / Low
$ 1.8399 / $ 0.3601
Market Cap
53,634,096
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.18

Intraday Chart

Shares Traded

Share Volume:
162,611
50 Day Avg. Daily Volume:
1,182,290

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.22

Trading Range

The current last sale of $0.371 is 3.03% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.3898 $ 1.8399
 Low: $ 0.3631 $ 0.3601

Company Description (as filed with the SEC)

Our legal and commercial name is BioLineRx Ltd. We are a company limited by shares organized under the laws of the State of Israel. Our principal executive offices are located at 2 HaMa'ayan Street, Modi'in 7177871, Israel, and our telephone number is +972 (8) 642-9100. We were founded in 2003 by leading institutions in the Israeli life sciences industry. We completed our initial public offering in Israel in February 2007 and our ordinary shares are traded on the TASE under the symbol "BLRX." In July 2011, we listed our ADSs on Nasdaq and they are traded under the symbol "BLRX." In March 2017, we acquired Agalimmune Ltd., a private U.K.-based company, and its U.S. subsidiary, Agalimmune Inc. Agalimmune Inc. was dissolved on December 31, 2017. Our capital expenditures for the years ended December 31, 2016 and 2018 were immaterial. For the year ended December 31, 2017, our capital expenditures were $0.3 million.  ... More ...  



Risk Grade

Where does BLRX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.377
Open Date:
Apr. 22, 2019
Close Price:
N/A
Close Date:
N/A


Consensus Recommendation

Analyst Info